Original Article| Volume 14, ISSUE 1, P19-24, March 2005

Download started.


Factors Influencing the Mean Postoperative Gradients Across Stentless Porcine Valves


      To study the preoperative and intraoperative variables influencing the mean post-operative transvalvular gradient across stentless porcine valves.


      From 1995 to 2002, 84 patients underwent stentless valve insertion. The mean age was 73 years, and 63% were male. The valve pathology was aortic stenosis (AS) in 79%, aortic regurgitation (AR) in 12%, and mixed in 9%. Valve sizes ranged from 21 to 29 with size 27 being most frequent. 54% of patients had concomitant procedures. Patients had at least yearly clinical and echocardiographic follow-up.


      There was no operative mortality. 9.5% of the patients had significant postoperative complications. The average echo interval was 18.6 months (range 1–88). The overall mean transvalvular gradient was 9.88 ± 5.67 (SD) mmHg. Variables associated with significantly reduced gradients were: larger valve sizes (p = 0.002), younger age (p = 0.05), pre-op AR (p = 0.008), and increasing post-operative interval (p = 0.05). The mean gradients decreased by 0.28 mmHg for each post-operative year. The method of implantation did not significantly affect gradients (p = 0.26).


      Excellent mean transvalvular gradients were achieved with stentless valves studied, with a low operative risk. The gradients did not appear to be related to intra-operative factors, suggesting that insertion techniques can be tailored to suit patient conditions and surgeon preferences.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Heart, Lung and Circulation
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • David T.E.
        • Pollick C.
        • Bos J.
        Aortic valve replacement with stentless procine aortic bioprosthesis.
        J Thorac Cardiovasc Surg. 1990; : 113-118
        • Levy D.
        • Garrison R.J.
        • Savage D.D.
        Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.
        N Engl J Med. 1990; 322: 1561-1566
        • Lund O.
        Valve replacement for aortic stenosis: the curative potential of early operation.
        Scand J Thorac Cardiovasc Surg. 1993; 40: 1-137
        • Bach D.S.
        • Goldman B.
        • Verrier E.
        • Petracek M.
        • Wood J.
        • David T.
        • et al.
        Impact of small valve size on hemodynamics and left ventricular mass regression with the Toronto SPV stentless aortic bioprosthesis.
        J Heart Valve Dis. 2002; 11: 236-241
        • Jin X.Y.
        • Gibson D.G.
        • Yacoub M.H.
        • Pepper J.R.
        Perioperative assessment of aortic homograft, Toronto stentless valve, and stented valve in the aortic position.
        Ann Thorac Surg. 1995; 60: S395-S401
      1. Jin XY, Gibson DG, Pepper JR. Left ventricular function after aortic valve replacement. Annual of cardiac surgery, 8th ed. London: Current Science; 1995. p. 125–134.

        • Jin X.Y.
        • Zhang Z.M.
        • Gibson D.G.
        Effects of valve substitute on changes in ventricular function and hypertrophy after aortic valve replacement. 1996; 62: 683-690
        • Armitage P.
        • Berry G.
        Statistical methods in medical research.
        Blackwell, Oxford1987
        • Reardon M.J.
        • David T.E.
        Stentless xenograft aortic valves.
        Curr Opin Cardiol. 1999; 14: 84-89
      2. Greve H, Farah I, Everlien M. Comparison of three different types of stentless valves: full root or subcoronary. Ann Thorac Surg 2001;71:S293–6.

        • Vesely I.
        • Boughner D.
        • Song T.
        Tissue buckling as a mechanism of bioprosthetic valve failure.
        Ann Thorac Surg. 1988; 46: 302-308
        • Goldman B.
        • Christakis G.
        • David T.
        Will stentless valves be durable? The Toronto valve at 5 to 6 years.
        Semin Thorac Cardiovasc. 1999; 11: 42-49
        • Flomenbaum M.A.
        • Schoen F.J.
        Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves.
        J Thorac Cardiovasc Surg. 1993; 105: 154-164
        • Luciani G.
        • Casali G.
        • Auriemma S.
        Survival after stentless and stented xenograft aortic valve replacement: a concurrent controlled trial.
        Ann Thorac. 2002; 74: 1443-1449
        • David T.
        • Puschmann R.
        • Ivanov J.
        Aortic valve replacement with stentless and stented porcine valves: a case matched study.
        J Thorac Cardiovasc Surg. 1998; 116: 236-241
        • Ali A.
        • Lim E.
        • Halstead J.
        Porcine or human stentless valves for aortic valve replacement? Results of a 10-year comparative study.
        J Heart Valve Dis. 2003; 12: 430-435
        • Blackstone E.H.
        • Cosgrove D.M.
        • Jamieson E.R.
        Prosthesis size and long-term survival after aortic valve replacement.
        J Thorac Cardiovasc Surg. 2003; 126: 783-796
        • Cohen G.
        • Christakis G.T.
        • Joyner C.D.
        Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial.
        Ann Thorac Surg. 2002; 73: 767-778
        • Krayenbuehl H.
        • Hess O.M.
        • Monrad S.
        • Schneider J.
        • Mall G.
        • Turina M.
        Left ventricular myocardial structure in aortic valve disease before, intermediate, and later after aortic valve replacement.
        Circulation. 1989; 79: 744-755
        • Nagy Z.L.
        • Fisher J.
        • Walker P.G.
        • Watterson K.G.
        The effect of sizing on the in vitro hydrodynamic characteristics and leaflet motion of the Toronto SPV stentless valve.
        J Thorac Cardiovasc Surg. 1999; 117: 92-98
        • Troy B.L.
        • Pombo J.
        • Rackley C.E.
        Measurement of left ventricular wall thickness and mass by echocardiography.
        Circulation. 1972; 45: 602-611
        • Task Force of the Echocardiography Section of the Canadian Cardiovascular Society, the Canadian Hypertension Society
        Guidelines from the Canadian Cardiovascular Society and the Canadian Hypertension Society on the echocardiographic determination of left ventricular mass.
        Can J Cardiol. 1995; 11: 391-395
        • Sahn D.J.
        • Demaria A.
        • Kisslo J.
        • Weyman A.
        The committee on M-mode standardization of American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.
        Circulation. 1978; 58: 1072-1083
        • Upton M.T.
        • Gibson D.G.
        The study of left ventricular function from digitized echocardiograms.
        Prog Cardiovasc Dis. 1978; 20: 359-384
        • Devereux R.B.
        • Reichek N.
        Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
        Circulation. 1977; 55: 613-618
        • Lee C.H.
        • Hogan J.C.
        • Gibson D.G.
        Diastolic disease in left ventricular hypertrophy: comparison of M-mode and Doppler echocardiography for the assessment of rapid ventricular filling.
        Br Heart J. 1991; 65: 194-200
        • Williams R.J.
        • Muir D.F.
        • Pathi V.
        Randomized control trials of stented and stentless aortic bioprosthesis: hemodynamic performance at 3 years.
        Semin Thoracic Cardiovasc Surg. 1999; 11: 93-97
        • Dellgren G.
        • Eriksson M.J.
        • Blange I.
        • Brodin L.A.
        • Radegran K.
        • Sylven C.
        Angiotensin-converting enzyme gene polymorphism influences degree of left ventricular hypertrophy and its regression in patients undergoing operation for aortic stenosis.
        Am J Cardiol. 1999; 84: 909-913